Molecular Partners AG annual shareholders’ equity
2019
2020
2021
2022
2023
2024
2025
Molecular Partners AG Shareholders’ Equity Growth & History (MOLN)
Molecular Partners AG's shareholders’ equity was CHF80.3M for fiscal 2025.
View full Molecular Partners AG company overviewMolecular Partners AG annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF80.3M | −CHF61.3M | −43.28% |
| 2024 | 2024-12-31 | CHF141.6M | −CHF34.8M | −19.72% |
| 2023 | 2023-12-31 | CHF176.4M | −CHF58.7M | −24.98% |
| 2022 | 2022-12-31 | CHF235.2M | CHF127.9M | +119.19% |
| 2021 | 2021-12-31 | CHF107.3M | CHF69,000 | +0.06% |
| 2020 | 2020-12-31 | CHF107.2M | CHF53.1M | +98.05% |
| 2019 | 2019-12-31 | CHF54.1M | — | — |
Molecular Partners AG quarterly shareholders’ equity
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF58.5M | −CHF48.1M | −45.11% |
| Q1 2026 | 2026-03-31 | CHF68.5M | −CHF59.7M | −46.60% |
| Q4 2025 | 2025-12-31 | CHF80.3M | −CHF61.3M | −43.28% |
| Q3 2025 | 2025-09-30 | CHF95.5M | — | — |
| Q2 2025 | 2025-06-30 | CHF106.7M | −CHF48.9M | −31.44% |
| Q1 2025 | 2025-03-31 | CHF128.2M | — | — |
| Q4 2024 | 2024-12-31 | CHF141.6M | −CHF34.8M | −19.72% |
| Q2 2024 | 2024-06-30 | CHF155.6M | −CHF50.4M | −24.47% |
| Q4 2023 | 2023-12-31 | CHF176.4M | −CHF58.7M | −24.98% |
| Q2 2023 | 2023-06-30 | CHF206.0M | −CHF59.9M | −22.53% |
| Q4 2022 | 2022-12-31 | CHF235.2M | CHF127.9M | +119.19% |
| Q2 2022 | 2022-06-30 | CHF265.9M | — | — |
| Q4 2021 | 2021-12-31 | CHF107.3M | — | — |
Molecular Partners AG shareholders’ equity trends
Over the last five fiscal years, Molecular Partners AG's shareholders’ equity decreased from CHF107.2M to CHF80.3M, a change of −CHF26.9M. The latest reported quarter, Q2 2026, shows CHF58.5M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Molecular Partners AG source filings ↗